Drs. Kantarjian, Litzow Discuss Blinatumomab Breakthrough in E1910 Trial
https://youtu.be/xP3dZWHtfKs In this video filmed at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024), Hagop Kantarjian,MD, professor and chair
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Roundtable Discussions
Leukemia
Acute Myeloid Leukemia
Roundtable Discussions
Video Interviews
Dr. Craddock Issues Rallying Cry to Leukemia Transplant Community
Hagop Kantarjian, MD, professor and chair in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, sits down with
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Is Blinatumomab Plus Chemotherapy in MRD-Negative BCP-ALL Superior to Chemotherapy-alone?
The addition of the bispecific T-cell engager blinatumomab to consolidation chemotherapy in adults patients with BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who had
Society Updates
SOHO President Dr. Scheinberg Announces Joint Session With ABHH in Brazil in October
For the first time in history, the Society of Hematologic Oncology (SOHO) is holding a joint session with the Brazilian Association of Hematology,